Skip to main content

Mickael Decressac, PhD

Assistant Investigator at Telethon Institute of Genetics and Medicine (TIGEM) – Telethon Foundation

Location: Pozzuoli Italy

Mickael Decressac, PhD, is a junior investigator at the Telethon Institute of Genetics and Medicine (TIGEM) in Pozzuoli, Italy. In 2012, he developed a viral vector-based model of Parkinson’s disease, which is widely used for studying the pathological mechanisms and testing protective therapies. Notably, he used this model to uncover novel mechanisms underlying the response of affected neurons to neurotrophic factors and contributed to understanding how the cellular clearance pathways are involved in the disease process. His current research is focused on understanding and modeling Parkinson’s disease as well as developing new therapeutic approaches using translational approaches.

Associated Grants

  • Modulating Aging-controlling Pathways in Pre-clinical models of Parkinson’s Disease


  • Validation of IGF-1 as a Neuroprotective Agent in Pre-clinical Models of Parkinson’s Disease


  • Pre-clinical Validation of a Nurr1 Agonist for Neuroprotection in Parkinson’s Disease


  • Neurotrophic and Autophagic Markers in Parkinson’s Disease: Implications for Disease-modifying Strategies


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.